FDA: Merck’s Januvia may have pancreatitis risk

The Food and Drug Administration  said on Friday that there may be a connection between Merck & Co.’s diabetes treatment Januvia and occurrences of acute pancreatitis, the same issue that sunk sales of Amylin Pharmaceuticals Inc.’s Byetta. Still, the agency reaffirms it is unclear whether the connection is between the treatment and pancreatitis or whether diabetes patients in general are at an increased risk. The FDA said there were 88 cases of acute pancreatitis reported in Januvia patients between October of 2006 and February of 2009. The agency is working with Merck to include new warning information on the drug’s label.

Click here to read more…

2 Responses to “FDA: Merck’s Januvia may have pancreatitis risk”


  1. 1 tamara February 16, 2011 at 5:48 pm

    my husband took januvia and in April of 2010 he had panceratitis and has been out of work and had surgeries and in hospital almost every month some times 3months at a time caused by januvia

  2. 2 Mari March 29, 2013 at 5:30 pm

    Nice post. I was checking continuously this blog and I am impressed!
    Very helpful information specifically the last part 🙂 I care for such info
    much. I was looking for this certain info for a long time.
    Thank you and best of luck.
    See this: Mari, http://whisperings.wroclaw.pl


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 434 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.


%d bloggers like this: